Brief: Renovorx Initiates Patient Enrollment At University Of Texas Southwestern Medical Center For Pivotal Phase Iii Tiger-Pac Clinical Trial
01/06/2023 13:48
June 1 (Reuters) - RenovoRx Inc RNXT.O :
* RENOVORX INITIATES PATIENT ENROLLMENT AT UNIVERSITY OF
TEXAS
SOUTHWESTERN MEDICAL CENTER FOR PIVOTAL PHASE III TIGER-PAC
CLINICAL TRIAL
* RENOVORX INITIATES PATIENT ENROLLMENT AT UNIVERSITY OF
TEXAS
SOUTHWESTERN MEDICAL CENTER FOR PIVOTAL PHASE III TIGER-PAC
CLINICAL TRIAL
Source text for Eikon: ID:nBw9zsNXWa
Further company coverage: RNXT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RenovoRx
See all newsBrief: RenovoRx Gets FDA Orphan Drug Designation For Oxaliplatin To Treat Pancreatic Cancer
RenovoRx Q1 revenue rises as number of active cancer centers increase
RenovoRx 2025 net loss widens on higher operating expenses
Brief: RenovoRx FY Net Income USD -11.168 Million
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies